128 related articles for article (PubMed ID: 8824714)
21. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
Schmidli RS; Colman PG; Harrison LC
J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
[TBL] [Abstract][Full Text] [Related]
23. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
[TBL] [Abstract][Full Text] [Related]
24. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
[TBL] [Abstract][Full Text] [Related]
25. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry.
Vandewalle CL; Falorni A; Svanholm S; Lernmark A; Pipeleers DG; Gorus FK
J Clin Endocrinol Metab; 1995 Mar; 80(3):846-51. PubMed ID: 7883841
[TBL] [Abstract][Full Text] [Related]
26. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Borg H; Fernlund P; Sundkvist G
Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
29. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
De Aizpurua HJ; Wilson YM; Harrison LC
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ
Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024
[TBL] [Abstract][Full Text] [Related]
31. Detection of glutamic acid decarboxylase (GAD) autoantibodies by indirect immunofluorescence using CHO cells expressing recombinant human GAD65.
Papouchado ML; Ermácora MR; Poskus E
J Autoimmun; 1996 Oct; 9(5):689-97. PubMed ID: 8933286
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies.
Kawasaki E; Abiru N; Yano M; Uotani S; Matsumoto K; Matsuo H; Yamasaki H; Yamamoto H; Yamaguchi Y; Akazawa S
J Autoimmun; 1995 Oct; 8(5):633-43. PubMed ID: 8579720
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset.
Dotta F; Falorni A; Tiberti C; Dionisi S; Anastasi E; Torresi P; Lernmark A; Di Mario U
J Autoimmun; 1997 Dec; 10(6):585-8. PubMed ID: 9451598
[TBL] [Abstract][Full Text] [Related]
34. Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes.
Williams AJ; Lampasona V; Wyatt R; Brigatti C; Gillespie KM; Bingley PJ; Achenbach P
Diabetes; 2015 Sep; 64(9):3247-52. PubMed ID: 26001397
[TBL] [Abstract][Full Text] [Related]
35. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
36. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.
Wyatt RC; Brigatti C; Liberati D; Grace SL; Gillard BT; Long AE; Marzinotto I; Shoemark DK; Chandler KA; Achenbach P; Gillespie KM; Piemonti L; Lampasona V; Williams AJK
Diabet Med; 2018 Jul; 35(7):954-963. PubMed ID: 29577424
[TBL] [Abstract][Full Text] [Related]
37. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
Roll U; Nuber A; Schröder A; Gerlach E; Janka HU; Ziegler AG
Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299
[TBL] [Abstract][Full Text] [Related]
38. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
[TBL] [Abstract][Full Text] [Related]
39. HLA-DR, DQ and anti-GAD antibodies in first degree relatives of type I diabetes mellitus.
Serrano-Ríos M; Gutierrez-López MD; Pérez-Bravo F; Martínez MT; Antona J; Rowley M; Mackay I; Zimmet P
Diabetes Res Clin Pract; 1996 Oct; 34 Suppl():S133-9. PubMed ID: 9015682
[TBL] [Abstract][Full Text] [Related]
40. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]